表紙
市場調査レポート

脊椎手術における医療機器技術の世界市場 (2014〜2021年) :南北アメリカ、欧州、アジア太平洋地域および他の諸国における既存製品と新興製品、技術および市場

Global Market For Medical Device Technologies in Spine Surgery 2014-2021: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World

発行 MedMarket Diligence, LLC 商品コード 339686
出版日 ページ情報 英文 384 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
脊椎手術における医療機器技術の世界市場 (2014〜2021年) :南北アメリカ、欧州、アジア太平洋地域および他の諸国における既存製品と新興製品、技術および市場 Global Market For Medical Device Technologies in Spine Surgery 2014-2021: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World
出版日: 2015年08月31日 ページ情報: 英文 384 Pages
概要

当レポートでは、世界の脊椎手術における医療機器技術市場について調査し、製品セグメントの概要、北米、欧州、アジア太平洋地域などの地域別動向、参入企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 脊柱、脊椎損傷および疾患のイントロダクション

  • 脊柱と関連構造
  • 脊椎疾患

第2章 脊椎損傷および脊椎疾患のための外科的処置

第3章 現在の製品および技術レビュー、新興技術および最新動向

  • イントロダクション
  • 現在の製品セグメント
    • 頸部インプラント
    • 胸腰部インプラント装置
    • 低侵襲性インプラントおよび手術
    • 非固定インプラント
    • オルソバイオロジクス

第4章 世界の脊椎疾患治療に用いられる医療機器市場サマリー

  • イントロダクション
  • 市場収益分析
  • 市場シェア分析

第5章 北米市場:レビューと分析

  • イントロダクション
  • 法規制要件
    • 米国
    • カナダ
  • 市場動向
    • 市場促進因子
    • 市場阻害因子
    • 米国における脊椎固定市場の今後の発展予測
  • 市場収益分析
  • 北米:市場シェア分析

第6章 欧州市場レビューと分析

  • イントロダクション
  • 法規制要件
  • 市場動向
    • 市場促進因子
    • 市場阻害因子
  • 市場収益分析
  • 欧州:市場シェア分析

第7章 アジア太平洋地域市場レビューと分析

  • イントロダクション
  • 法規制要件
  • 市場動向
    • 市場促進因子
    • 市場阻害因子
  • 市場収益分析
  • アジア太平洋地域:市場シェア分析

第8章 その他の市場:レビューと分析

  • イントロダクション
  • ブラジル
  • アルゼンチン
  • メキシコ
  • 市場動向
    • 市場促進因子
    • 市場阻害因子
  • 市場収益分析

第9章 企業プロファイル

付録

図表

目次
Product Code: M540

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes the diseases and disorders of the spine, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in spine surgery. The report provides a current and forecast to 2021 by region/country of procedures and manufacturer revenues for, specifically, Americas (United States, Rest of North America, Latin America), European Union (United Kingdom, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Rest of Asia/Pacific) and Rest of World. The forecast addresses the product- and country-specific impacts in the market of new technologies through the coming decade. The report profiles 38 of the most notable current and emerging companies in this industry, providing status and forecast data on their current products, current market position, and products under development.

Table of Contents

EXECUTIVE SUMMARY

SECTiON 1: INTRODUCTION TO THE SPINAL COLUMN, SPINAL INJURIES AND DISORDERS

  • 1.1 The Spinal Column and Associated Structures
    • 1.1.1 Cervical Vertebrae (C1 - C7)
    • 1.1.2 Thoracic Vertebrae (T1 - T12)
    • 1.1.3 Lumbar Vertebrae (L1 - L5)
    • 1.1.4 Sacral Spine
    • 1.1.5 Intervertebral Discs
    • 1.1.6 Purpose of the Vertebrae
    • 1.1.7 The Nerve Structure of the Spine
      • 1.1.7.1 The Central Nervous System (CNS)
      • 1.1.7.2 The Peripheral Nervous System (PNS)
    • 1.1.8 Other Spinal Cord and Nerve Structures
      • 1.1.8.1 Cerebrospinal Fluid (CSF)
      • 1.1.8.2 Meninges
      • 1.1.8.3 Dermatomes
      • 1.1.8.4 Bone Physiology and the Process of Healing
  • 1.2 Spinal Disorders
    • 1.2.1 Degenerative Disorders
      • 1.2.1.1 Degenerative Disc Disease (DDD)
      • 1.2.1.2 Herniated Disc
      • 1.2.1.3 Spinal Stenosis
      • 1.2.1.4 Spondylosis
      • 1.2.1.5 Spondylolisthesis
      • 1.2.1.6 Osteoporosis
      • 1.2.1.7 Rheumatoid Arthritis
      • 1.2.1.8 Paget's Disease
      • 1.2.1.9 Spinal Trauma
      • 1.2.1.10 Spinal Deformities
      • 1.2.1.11 Spinal Tumors

SECTION 2: SURGICAL PROCEDURES FOR SPINAL INJURIES AND DISORDERS

  • 2.1 Introduction
  • 2.2 Anterior Lumbar Interbody Fusion (ALIF)
  • 2.3 Anterior Cervical Corpectomy
  • 2.4 Anterior Cervical Discectomy and Fusion (ACDF)
  • 2.5 Axial Lumbar Interbody Fusion (AXiaLIF)
  • 2.6 Cervical Laminaplasty
  • 2.7 Cervical Posterior Foraminotomy
  • 2.8 Direct Lateral Interbody Fusion (DLIF)
  • 2.9 Discectomy
  • 2.10 Endoscopic Surgery
  • 2.11 eXtreme Lateral Interbody Fusion (XLIF)
  • 2.12 Foraminotomy and Foraminectomy
  • 2.13 Intradiscal Electrothermal Therapy (IDET)
  • 2.14 Kyphoplasty
  • 2.15 Laminectomy
  • 2.16 Laminoplasty
  • 2.17 Laminotomy
  • 2.18 LASER Surgery
  • 2.19 Microdiscectomy (Minimally Invasive Technique)
  • 2.20 Oblique Lumbar Interbody Fusion (PLIF)
  • 2.21 Posterior Lumbar Interbody Fusion (PLIF)
  • 2.22 Scoliosis Correction
  • 2.23 Spinal Decompression
  • 2.24 Spinal Fusion
  • 2.25 Spinal Instrumentation
  • 2.26 Spinal Osteotomy
  • 2.27 Thoracoscopic Release
  • 2.28 Transforamenal Lumbar Interbody Fusion (TLIF)

SECTION 3: CURRENT PRODUCT AND TECHNOLOGY REVIEW, EMERGING TECHNOLOGIES AND LATEST DEVELOPMENTS

  • 3.1 Introduction
  • 3.2 Current Product Segments
    • 3.2.1 Cervical Implants
      • 3.2.1.1 Background and Market Segmentation
      • 3.2.1.2 Selected Cervical Implants and Technologies
    • 3.2.2 Thoracolumbar Implant Devices
      • 3.2.2.1 Background and Market Segmentation
    • 3.2.3 Minimally Invasive Implants and Surgery
    • 3.2.4 Non Fusion Implants
      • 3.2.4.1 Artificial Disc Replacement Implants
      • 3.2.4.2 Interspinous Implants
    • 3.2.5 Orthobiologics
      • 3.2.5.1 Demineralised Bone Matrix (DBM)
      • 3.2.5.2 Synthetic Bone Graft Substitutes

SECTION 4: SUMMARY GLOBAL MARKET FOR MEDICAL DEVICES USED TO TREAT SPINAL DISORDERS

  • 4.1 Introduction
  • 4.2 Market Revenue Analysis
    • 4.2.1 Global: Market Revenue Analysis
    • 4.2.2 Global Market Revenue Analysis by Individual Region
    • 4.2.3 Global Market Revenue Analysis by Individual Market Segments
  • 4.3 Market Share Analysis
    • 4.3.1 Global Market Share Analysis
    • 4.3.2 Market Share Analysis by Selected Market Segment

SECTION 5: THE NORTH AMERICAN MARKET: REVIEW AND ANALYSIS

  • 5.1 Introduction
  • 5.2 Regulatory and Legislative requirements
    • 5.2.1 United States
      • 5.2.1.1 Medical Devices Regulations (FDA)
      • 5.2.1.2 FDA Classification of Spinal Systems
      • 5.2.1.3 Centers for Medicare & Medicaid Services (CMS)
      • 5.2.1.4 The 2010 Affordable Care Act
      • 5.2.1.5 Private Insurance
      • 5.2.1.6 Summary of Health Insurance Coverage in the United States
      • 5.2.1.1 The Reimbursement Process United States
    • 5.2.2 Canada
  • 5.3 Market Dynamics
    • 5.3.1 Market Drivers
      • 5.3.1.1 Increased Rates of Spinal Fusions in the United States
      • 5.3.1.2 Significant Advances in Implant Design and Materials Helps Stimulate Market Development
      • 5.3.1.3 Continued Growth and Development of Minimally Invasive Spinal Fusion
    • 5.3.2 Market Restraints
      • 5.3.2.1 Cost Containment Issues Restrain Growth and Development of the Implant Industry
      • 5.3.2.2 Reimbursement Coverage Crisis for Minimally Invasive Spinal Surgery in the United States
      • 5.3.2.3 Spinal Fusion Cost and Imbursement Issues (Impact of The Affordable Care Act and Increased Scrutiny by the Centers for Medicare & Medicaid Services (CMS)
      • 5.3.2.4 Medicare MACs and RACs finding high error rates with spinal fusion DRG-460
      • 5.3.2.5 Increased Transparency of Spine Reimbursement Numbers Highlights Discrepancies Across Hospitals
    • 5.3.3 Anticipated Key Market Development in the Spinal Fusion Market in the United States
  • 5.4 Market Revenue Analysis
    • 5.4.1 North America: Market Revenue Analysis (Spinal Fusion)
    • 5.4.2 North America: Market Revenue Analysis by Market Segment
      • 5.4.2.1 North America: Market Revenue Analysis (Cervical Fusion)
      • 5.4.2.2 North America: Market Revenue Analysis (Thoracolumbar Fusion)
      • 5.4.2.3 North America: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
      • 5.4.2.4 North America: Market Revenue Analysis (Interbody Fusion Devices)
      • 5.4.2.5 North America: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
    • 5.4.3 North America: Market Revenue Analysis by Selected Individual Country
  • 5.5 North America: Market Share Analysis
    • 5.5.1 North America: Market Share Analysis by Individual Market Segments

SECTION 6: THE EUROPEAN MARKET REVIEW AND ANALYSIS

  • 6.1 Introduction
  • 6.2 Regulatory and Legislative requirements
    • 6.2.1 General) Medical Device Directive, MDD (93/42/EEC)
    • 6.2.2 Active Implantable Medical Device Directive, AIMDD (90/385/EEC)
    • 6.2.3 In Vitro Diagnostic Medical Device Directive, IVDMDD (98/79/EC)
    • 6.2.4 Proposal for Changes to the Medical Device Directive, MDD (93/42/EEC)
    • 6.2.5 Notified Bodies
    • 6.2.6 Medical Devices Legislation and Regulations: The Russian Federation
  • 6.3 Market Dynamics
    • 6.3.1 Market Drivers
      • 6.3.1.1 Technological Advances in Product Design and Material Innovations Help Stimulate the Market
      • 6.3.1.2 Increased Incidence of Degenerative Disease of the Lower Back Market
      • 6.3.1.3 Creation of Lucrative Private Healthcare Spinal Fusions Market
      • 6.3.1.4 Emergence of Minimally Invasive Spinal Surgery
    • 6.3.2 Market Restraints
      • 6.3.2.1 Cost Containment and Reimbursement Issues Significantly Affect Market Growth for Spinal Implants
      • 6.3.2.2 Concerns over the Appropriate Use of Pedicular Screw Fixation
      • 6.3.2.3 Increased Competitive Activity and Competitive Product Pricing Regarded as a Major Market Restraint
  • 6.4 Market Revenue Analysis
    • 6.4.1 Europe: Market Revenue Analysis (Spinal Fusion)
    • 6.4.2 Europe: Market Revenue Analysis by Market Segment
      • 6.4.2.1 Europe: Market Revenue Analysis (Cervical Fusion)
      • 6.4.2.2 Europe: Market Revenue Analysis (Thoracolumbar Fusion)
      • 6.4.2.3 Europe: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
      • 6.4.2.4 Europe: Market Revenue Analysis (Interbody Fusion Devices)
      • 6.4.2.5 Europe: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
    • 6.4.3 Europe: Market Revenue Analysis by Selected Individual Country
  • 6.5 Europe: Market Share Analysis
    • 6.5.1 Europe: Market Share Analysis by Individual Market Segments

SECTION 7: THE ASIA/PACIFIC MARKET REVIEW AND ANALYSIS

  • 7.1 Introduction
    • 7.1.1 Japan
      • 7.1.1.1 Regulatory and Legislative Requirements
      • 7.1.1.2 Marketing Authorization System
    • 7.1.2 China
      • 7.1.2.1 Overview of the Healthcare System
      • 7.1.2.2 Healthcare Reforms
    • 7.1.3 India
      • 7.1.3.1 Overview of the Healthcare System
    • 7.1.4 South Korea
  • 7.2 Market Dynamics
    • 7.2.1 Market Drivers
      • 7.2.1.1 Growth and Development of Spinal Fusion Market in the Booming Economies in Emerging Markets
      • 7.2.1.2 Growth and Development of the Chinese Market
      • 7.2.1.3 Growth and Development of the Indian Market
    • 7.2.2 Market Restraints
      • 7.2.2.1 China
      • 7.2.2.2 India
      • 7.2.2.3 Japan
  • 7.3 Market Revenue Analysis
    • 7.3.1 Asia Pacific: Market Revenue Analysis
    • 7.3.2 Asia Pacific: Market Revenue Analysis by Market Segment
      • 7.3.2.1 Asia Pacific: Market Revenue Analysis (Cervical Fusion)
      • 7.3.2.2 Asia Pacific: Market Revenue Analysis (Thoracolumbar Fusion)
      • 7.3.2.3 Asia Pacific: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
      • 7.3.2.4 Asia Pacific: Market Revenue Analysis (Interbody Fusion Devices)
      • 7.3.2.5 Asia Pacific: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
    • 7.3.3 Asia Pacific: Market Revenue Analysis by Selected Individual Country
  • 7.4 Asia Pacific: Market Share Analysis
    • 7.4.1 Asia Pacific: Market Share Analysis by Individual Market Segments

SECTION 8: THE REST OF THE WORLD MARKET: REVIEW AND ANALYSIS

  • 8.1 Introduction
  • 8.2 Brazil
    • 8.2.1 Background
    • 8.2.2 Regulatory and Legislative Requirements
    • 8.2.3 Market Entry and Reimbursement of Medical Devices: Brazil
  • 8.3 Argentina
    • 8.3.1 Background
    • 8.3.2 Government-funded Public Health Sector
    • 8.3.3 Social Health Insurance Sector
    • 8.3.4 Private sector
    • 8.3.5 Regulatory and Legislative Requirements
  • 8.4 Mexico
    • 8.4.1 Legislation and Regulations Governing Medical Devices in Mexico
    • 8.4.2 Health Insurance Structure Mexico
  • 8.5 Market Dynamics
    • 8.5.1 Market Drivers
      • 8.5.1.1 Significant Market growth Opportunities in Brazil
      • 8.5.1.2 Brazilian Government Incentives Favor Local Development and Production
      • 8.5.1.3 Expansion of Healthcare Opportunities in Mexico
      • 8.5.1.4 Introduction of Tax Funded Universal Health Coverage Throughout Latin America
      • 8.5.1.5 Aging Populations in Central and Latin America Set to Increase Burden of Low Back Pain
    • 8.5.2 Market Restraints
      • 8.5.2.1 Diverse Regulatory Environment Constrains Latin American Medical Device Market
      • 8.5.2.2 Challenges Associated with Local Business Practices and Cultural Conditions in Brazil
      • 8.5.2.3 Issues Associated with the Distribution of Medical Devices in Latin America
      • 8.5.2.4 Pricing Issues
      • 8.5.2.5 Increased Use and Reliance on Health Technology Assessments (HTAs), Tenders and Fixed Reimbursement Rates
      • 8.5.2.6 Importance of Local Companies Presence in Caribbean and Central and Latin American Countries
  • 8.6 Market Revenue Analysis
    • 8.6.1 Central and Latin America: Market Revenue Analysis
    • 8.6.2 Central and Latin America: Market Revenue Analysis by Market Segment
      • 8.6.2.1 Central and Latin America: Market Revenue Analysis (Cervical Fusion)
      • 8.6.2.2 Central and Latin America: Market Revenue Analysis (Thoracolumbar Fusion)
      • 8.6.2.3 Central and Latin America: Market Revenue Analysis (Minimally Invasive Spinal Fusion)
      • 8.6.2.4 Central and Latin America: Market Revenue Analysis (Interbody Fusion Devices)
      • 8.6.2.5 Central and Latin America: Market Revenue Analysis (Orthobiologics for Spinal Fusion)
    • 8.6.3 Central and Latin America: Market Revenue Analysis by Selected Individual Country
    • 8.6.4 Central and Latin America: Market Share Analysis
      • 8.6.4.1 Central and Latin America: Market Share Analysis by Individual Market Segments

SECTION 9: COMPANY PROFILES

  • 9.1 Accel Spine
  • 9.2 Alliance Spine
  • 9.3 Alphatec Spine
  • 9.4 Amedica
  • 9.5 Aesculap AG & Co AG a division of B. Braun Mesungen AG
  • 9.6 Apollo Spine
  • 9.7 A.W.M. Art World Medical
  • 9.8 Baumer S.A.
  • 9.9 Bonovo Orthopedic, Inc
  • 9.10 Centinel Spine
  • 9.11 coLigne AG
  • 9.12 Depuy Synthes(Johnson & Johnson)
  • 9.13 Dieter Marquardt Medizintechnik GmbH
  • 9.14 Exactech
  • 9.15 Globus Medical
  • 9.16 Integra Lifesciences (Sea Spine)
  • 9.17 Japan Medical Dynamic Marketing, Inc. (Japan MDM)
  • 9.18 K2M
  • 9.19 KYOCERA Medical Corporation
  • 9.20 LDR Holding Corporation
  • 9.21 Medicrea International
  • 9.22 Medtronic
  • 9.23 NuVasive
  • 9.24 Precision Spine
  • 9.25 SI-BONE
  • 9.26 Spineart
  • 9.27 SpineGuard
  • 9.28 Spine Surgical Innovations
  • 9.29 Spine Wave
  • 9.30 Stryker Inc
  • 9.31 Titan Spine
  • 9.32 TranS1
  • 9.33 Wright Medical Group, Inc. (Wright Medical Technology Inc.)
  • 9.34 Ulrich Medical
  • 9.35 Wenzel Spine
  • 9.36 X-spine
  • 9.37 Zimmer Biomet Holdings, Inc
  • 9.38 Zyga Technology

APPENDICES

  • Appendix 1: Company Addresses and Contact Details
  • Appendix 2: Glossary of Terminology

List of Exhibits

  • Exhibit ES-1: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit ES-2: Global Spine Market Forecast: Medical Device Technologies Used for Spinal Fusion by Region 2014
  • Exhibit ES-3: Global Spine Market Forecast, Medical Device Technologies Used for Spinal Fusion ($ millions) by Individual Segment 2014
  • Exhibit ES-4: Global Spine Market Forecast: Medical Device Technologies Used for Spinal Fusion ($ millions) by Individual Segment 2014
  • Exhibit ES-5: Global Market Share Analysis: Medical Device Technologies Used for Spinal Fusion 2014
  • Exhibit 1-1: Structure of the Vertebral Column
  • Exhibit 1-2: Structure of the Vertebral Column
  • Exhibit 1-3: Structure of the Cervical Vertebrae
  • Exhibit 1-4: Structure of the Thoracic Vertebrae
  • Exhibit 1-5: Structure of the Lumbar Vertebrae
  • Exhibit 1-6: Relationship between Intervertebral Disc and Vertebrae
  • Exhibit 1-7: Structure of the Intervertebral Disc
  • Exhibit 1-8: Functions of the Vertebral Column
  • Exhibit 1-9: Schematic Diagram of Relationship between the CNS and PNS
  • Exhibit 1-10: Spinal Nerves
  • Exhibit 1-11: Principle Structure and Relationship between Vertebrae and Spinal Nerves
  • Exhibit 1-12: Summary of the Normal Bone Remodeling-Normal Maintenance and Repair Process
  • Exhibit 1-13: Degenerative Spinal Disorders
  • Exhibit 1-14: Stages of Disc Herniation
  • Exhibit 1-15: Spinal Stenosis
  • Exhibit 1-16: Spinal Stenosis
  • Exhibit 1-17: Diagram of the Different Types of Scolosis
  • Exhibit 1-18: Diagram of Kyphosis
  • Exhibit 1-19: Diagram of Lordosis
  • Exhibit 3-1: Classification of Anterior Cervical Plates 6-
  • Exhibit 3-2: Constrained Rotational versus Constrained Translational Anterior Cervical Plates (ACPs)
  • Exhibit 4-1: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-2: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-3: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2014
  • Exhibit 4-4: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2021
  • Exhibit 4-5: Global Market: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion by region 2011 - 2021
  • Exhibit 4-6: North America: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-7: Europe: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-8: Asia Pacific: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-9: Central and Latin America: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-10: Global Market: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) By individual Segment 2014
  • Exhibit 4-11: Global Market: Revenue Forecasts, Medical Device Technologies Used For Spinal Fusion ($ millions) By individual Segment 2014
  • Exhibit 4-12: Global Market: Revenue Forecasts, Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 4-13: Global Market: Revenue Forecasts, Cervical Fusion ($ millions) by Geographic Region 2014
  • Exhibit 4-14: Global Market: Revenue Forecasts, Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 4-15: Global Market: Revenue Forecasts, Thoracolumbar Implants ($ millions) by Geographic Region 2014
  • Exhibit 4-16: Global Market: Revenue Forecasts, Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-17: Global Market: Revenue Forecasts, Minimally Invasive Spinal Fusion ($ millions) by Geographic Region 2014
  • Exhibit 4-18: Global Market: Revenue Forecasts, Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 4-19: Global Market: Revenue Forecasts, Interbody Fusion Devices ($ millions) by Geographic Region 2014
  • Exhibit 4-20: Global Market: Revenue Forecasts, Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 4-21: Global Market: Revenue Forecasts, Orthobiologics for Spinal Fusion ($ millions) by Geographic Region 2014
  • Exhibit 4-22: Global Market Share Analysis, Medical Device Technologies Used For Spinal Fusion 2014
  • Exhibit 4-23: Global Market Share Analysis, Medical Device Technologies Used For Spinal Fusion 2014
  • Exhibit 4-24: Global Market Share Analysis, Cervical Fusion, 2014
  • Exhibit 4-25: Global Market Share Analysis, Thoracolumbar Implants, 2014
  • Exhibit 4-26: Global Market Share Analysis, Minimally Invasive Spinal Fusion, 2014
  • Exhibit 4-27: Global Market Share Analysis, Interbody Fusion Devices, 2014
  • Exhibit 4-28: Global Market Share Analysis, Orthobiologics for Spinal Fusion, 2014
  • Exhibit 5-1: Private health insurance coverage among persons under age 65: United States, 2007-2011
  • Exhibit 5-2: Personal Health Care Expenditures; Aggregate and per Capita Amounts, Percent Distribution and Annual Percent Change by Source of Funds: Calendar Years 2006-2018 ($ Billions)
  • Exhibit 5-4: Hospital Discharges for Select Spine Procedures as a Proportion of All Spine Procedures, United States 2007 and 2011
  • Exhibit 5-5: North America: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-6: North America: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-7: North America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 5-8: North America: Revenue Forecasts: Cervical Infusion ($ millions) 2011 - 2021
  • Exhibit 5-9: North America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 5-10: North America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 5-11: North America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-12: North America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-13: North America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 5-14: North America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 5-15: North America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-16: North America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 5-17: United States: Spine Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 5-18: United States: Revenue for Cervical, Thoracolumbar and MIS Fusion ($ millions) 2011 - 2021
  • Exhibit 5-19: United States: Revenue for Interbody Fusion and Spine Orthobiologics ($ millions) 2011 - 2021
  • Exhibit 5-20: North America, Market Share Analysis Medical Device Technologies Used For Spinal Fusion (2014)
  • Exhibit 5-21: North America Market Share Analysis, Cervical Fusion, 2014
  • Exhibit 5-22: North America Market Share Analysis, Thoracolumbar Implants, 2014
  • Exhibit 5-23: North America Market Share Analysis, Minimally Invasive Spinal Fusion, 2014
  • Exhibit 5-24: North America Market Share Analysis, Interbody Fusion Devices, 2014
  • Exhibit 5-25: North America Market Share Analysis, Orthobiologics for Spinal Fusion, 2014
  • Exhibit 6-1: Europe: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021
  • Exhibit 6-2: Europe: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021
  • Exhibit 6-3: Europe: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 6-4: Europe: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 6-5: Europe: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 6-6: Europe: Revenue Forecasts: Thoracolumbar Implants ($ billions) 2011 - 2021
  • Exhibit 6-7: Europe: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 6-8: Europe: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 6-9: Europe: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 6-10: Europe: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 6-11: Europe: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 6-12: Europe: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 6-13: Germany: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-14: France: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-15: Italy: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-16: Spain: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-17: United Kingdom: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-18: Benelux: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-19: Scandinavia: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-20: Rest of Europe: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 6-21: Europe, Market Share Analysis, Spinal Implants and Associated Spinal Fusion Products (2014)
  • Exhibit 6-22: Europe Market Share Analysis, Cervical Fusion, 2014
  • Exhibit 6-23: Europe Market Share Analysis, Thoracolumbar Implants, 2014
  • Exhibit 6-24: Europe Market Share Analysis, Minimally Invasive Spinal Fusion, 2014
  • Exhibit 6-25: Europe Market Share Analysis, Interbody Fusion Devices, 2014
  • Exhibit 6-26: Europe Market Share Analysis, Orthobiologics for Spinal Fusion, 2014
  • Exhibit 7-1: Overview of Pharmaceutical Affairs Law (PAL) and Japanese Medical Devices Nomenclature (JMDN) codes and related codes according to the EU MDD
  • Exhibit 7-2: Reimbursement Categories: Japan
  • Exhibit 7-3: The Chinese Healthcare System
  • Exhibit 7-4: Number of Healthcare Institutions According to Ownership China, 2010
  • Exhibit 7-5: Total Number of Hospitals by Ranking China, 2010
  • Exhibit 7-6: Overview of Healthcare in India
  • Exhibit 7-7: Asia Pacific: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 7-8: Asia Pacific: Revenue Forecasts: Medical Device Technologies Used For Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 7-9: Asia Pacific: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 7-10: Asia Pacific: Revenue Forecasts: Cervical Infusion ($ millions) 2011 - 2021
  • Exhibit 7-11: Asia Pacific: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 7-12: Asia Pacific: Revenue Forecasts: Thoracolumbar Implants ($ billions) 2011 - 2021
  • Exhibit 7-13: Asia Pacific: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 7-14: Asia Pacific: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ billions) 2011 - 2021
  • Exhibit 7-15: Asia Pacific: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 7-16: Asia Pacific: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 7-17: Asia Pacific: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 7-18: Asia Pacific: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ billions) 2011 - 2021
  • Exhibit 7-19: China: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 7-20: India: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 7-21: Japan: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 7-22: Asia Pacific, Market Share Analysis, Medical Device Technologies Used For Spinal Fusion (2014)
  • Exhibit 7-23: Asia Pacific, Market Share Analysis, Cervical Fusion, 2014
  • Exhibit 7-24: Asia Pacific, Market Share Analysis, Thoracolumbar Implants, 2014
  • Exhibit 7-25: Asia Pacific, Market Share Analysis, Minimally Invasive Spinal Fusion, 2014
  • Exhibit 7-26: Asia Pacific, Market Share Analysis, Interbody Fusion Devices, 2014
  • Exhibit 7-27: Asia Pacific, Market Share Analysis, Orthobiologics for Spinal Fusion, 2014
  • Exhibit 8-1: Central and Latin America: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021
  • Exhibit 8-2: Central and Latin America: Revenue Forecasts: Spinal Implants and Associated Spinal Fusion Products ($ millions) 2011 - 2021
  • Exhibit 8-3: Central and Latin America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 8-4: Central and Latin America: Revenue Forecasts: Cervical Fusion ($ millions) 2011 - 2021
  • Exhibit 8-5: Central and Latin America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 8-6: Central and Latin America: Revenue Forecasts: Thoracolumbar Implants ($ millions) 2011 - 2021
  • Exhibit 8-7: Central and Latin America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 8-8: Central and Latin America: Revenue Forecasts: Minimally Invasive Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 8-9: Central and Latin America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 8-10: Central and Latin America: Revenue Forecasts: Interbody Fusion Devices ($ millions) 2011 - 2021
  • Exhibit 8-11: Central and Latin America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 8-12: Central and Latin America: Revenue Forecasts: Orthobiologics for Spinal Fusion ($ millions) 2011 - 2021
  • Exhibit 8-13: Argentina: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 8-14: Brazil: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 8-15: Mexico: Revenue Analysis: ($ millions) 2011 - 2021
  • Exhibit 8-16: Central and Latin America, Market Share Analysis, Spinal Implants and Associated Spinal Fusion Products (2014)
  • Exhibit 8-17: Central and Latin America Market Share Analysis, Cervical Fusion, 2014
  • Exhibit 8-18: Central and Latin America Market Share Analysis, Thoracolumbar Implants, 2014
  • Exhibit 8-19: Central and Latin America Market Share Analysis, Minimally Invasive Spinal Fusion, 2014
  • Exhibit 8-20: Central and Latin America Market Share Analysis, Interbody Fusion Devices, 2014
  • Exhibit 8-21: Central and Latin America Market Share Analysis, Orthobiologics for Spinal Fusion, 2014
Back to Top